{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:03:54Z","timestamp":1792890234123,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"A grant from the Department of Laboratory Medicine and Pathology (DLMP) to Viji Shridhar and Conde Gift to Dr. Julian Molina"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The metabolic signatures of cancer cells are often associated with elevated glycolysis. Pharmacological (PFK158 treatment) and genetic inhibition of 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 (PFKFB3), a critical control point in the glycolytic pathway, decreases glucose uptake, ATP production, and lactate dehydrogenase activity and arrests malignant pleural mesothelioma (MPM) cells in the G0\/G1 phase to induce cell death. To overcome this nutrient stress, inhibition of PFKFB3 activity led to an escalation in endoplasmic reticulum (ER) activity and aggravated ER stress mostly by upregulating BiP and GADD153 expression and activation of the endocytic Rac1-Rab5-Rab7 pathway resulting in a unique form of cell death called \u201cmethuosis\u201d in both the sarcomatoid (H28) and epithelioid (EMMeso) cells. Transmission electron microscopy (TEM) analysis showed the formation of nascent macropinocytotic vesicles, which rapidly coalesced to form large vacuoles with compromised lysosomal function. Both immunofluorescence microscopy and co-immunoprecipitation analyses revealed that upon PFKFB3 inhibition, two crucial biomolecules of each pathway, Rac1 and Calnexin interact with each other. Finally, PFK158 alone and in combination with carboplatin-inhibited tumorigenesis of EMMeso xenografts in vivo. Since most cancer cells exhibit an increased glycolytic rate, these results provide evidence for PFK158, in combination with standard chemotherapy, may have a potential in the treatment of MPM.<\/jats:p>","DOI":"10.1038\/s41419-019-1916-3","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T09:03:48Z","timestamp":1569575028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses"],"prefix":"10.1038","volume":"10","author":[{"given":"Sayantani","family":"Sarkar Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhu","family":"Thirusangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarshi","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-6643","authenticated-orcid":false,"given":"Deokbeom","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Staub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viji","family":"Shridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"1916_CR1","first-page":"319","volume":"110","author":"V Neumann","year":"2013","unstructured":"Neumann, V., Loseke, S., Nowak, D., Herth, F. J. & Tannapfel, A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch. Arztebl. Int. 110, 319\u2013326 (2013).","journal-title":"Dtsch. Arztebl. Int."},{"key":"1916_CR2","first-page":"70","volume":"12","author":"FE Mott","year":"2012","unstructured":"Mott, F. E. Mesothelioma: a review. Ochsner J. 12, 70\u201379 (2012).","journal-title":"Ochsner J."},{"key":"1916_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2471\/BLT.11.086678","volume":"89","author":"V Delgermaa","year":"2011","unstructured":"Delgermaa, V. et al. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull. World Health Organ. 89, 716\u2013724 (2011). 724A-724C.","journal-title":"Bull. World Health Organ."},{"key":"1916_CR4","first-page":"182","volume":"3","author":"W Zhang","year":"2015","unstructured":"Zhang, W., Wu, X., Wu, L., Zhang, W. & Zhao, X. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma. Ann. Transl. Med. 3, 182 (2015).","journal-title":"Ann. Transl. Med."},{"key":"1916_CR5","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","volume":"27","author":"AS Tsao","year":"2009","unstructured":"Tsao, A. S., Wistuba, I., Roth, J. A. & Kindler, H. L. Malignant pleural mesothelioma. J. Clin. Oncol. 27, 2081\u20132090 (2009).","journal-title":"J. Clin. Oncol."},{"key":"1916_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"1916_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1158\/1535-7163.MCT-13-0097","volume":"12","author":"BF Clem","year":"2013","unstructured":"Clem, B. F. et al. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. Mol. Cancer Ther. 12, 1461\u20131470 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"1916_CR8","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","volume":"2","author":"L Shi","year":"2017","unstructured":"Shi, L., Pan, H., Liu, Z., Xie, J. & Han, W. Roles of PFKFB3 in cancer. Signal Transduct. Target Ther. 2, 17044 (2017).","journal-title":"Signal Transduct. Target Ther."},{"key":"1916_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.292","volume":"5","author":"A Yalcin","year":"2014","unstructured":"Yalcin, A. et al. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis. 5, e1337 (2014).","journal-title":"Cell Death Dis."},{"key":"1916_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","volume":"154","author":"K De Bock","year":"2013","unstructured":"De Bock, K. et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651\u2013663 (2013).","journal-title":"Cell"},{"key":"1916_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ijc.31868","volume":"144","author":"S Mondal","year":"2019","unstructured":"Mondal, S. et al. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. Int. J. Cancer 144, 178\u2013189 (2019).","journal-title":"Int. J. Cancer"},{"key":"1916_CR12","doi-asserted-by":"publisher","first-page":"30778","DOI":"10.1074\/jbc.M205213200","volume":"277","author":"AS Marsin","year":"2002","unstructured":"Marsin, A. S., Bouzin, C., Bertrand, L. & Hue, L. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem. 277, 30778\u201330783 (2002).","journal-title":"J. Biol. Chem."},{"key":"1916_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/BJ20121886","volume":"452","author":"L Novellasdemunt","year":"2013","unstructured":"Novellasdemunt, L. et al. PFKFB3 activation in cancer cells by the p38\/MK2 pathway in response to stress stimuli. Biochem. J. 452, 531\u2013543 (2013).","journal-title":"Biochem. J."},{"key":"1916_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11060-007-9471-7","volume":"86","author":"R Kessler","year":"2008","unstructured":"Kessler, R., Bleichert, F., Warnke, J. P. & Eschrich, K. 6-Phosphofructo-2-kinase\/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. J. Neurooncol. 86, 257\u2013264 (2008).","journal-title":"J. Neurooncol."},{"key":"1916_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13046-016-0481-1","volume":"36","author":"HM Li","year":"2017","unstructured":"Li, H. M. et al. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. J. Exp. Clin. Cancer Res. 36, 7 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1916_CR16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.18388\/abp.2006_3308","volume":"53","author":"AY Bobarykina","year":"2006","unstructured":"Bobarykina, A. Y. et al. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochim. Pol. 53, 789\u2013799 (2006).","journal-title":"Acta Biochim. Pol."},{"key":"1916_CR17","first-page":"5881","volume":"62","author":"T Atsumi","year":"2002","unstructured":"Atsumi, T. et al. High expression of inducible 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res. 62, 5881\u20135887 (2002).","journal-title":"Cancer Res."},{"key":"1916_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fendo.2017.00261","volume":"8","author":"MV Recouvreux","year":"2017","unstructured":"Recouvreux, M. V. & Commisso, C. Macropinocytosis: a metabolic adaptation to nutrient stress in cancer. Front. Endocrinol. 8, 261 (2017).","journal-title":"Front. Endocrinol."},{"key":"1916_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"1916_CR20","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1242\/jcs.176149","volume":"129","author":"G Bloomfield","year":"2016","unstructured":"Bloomfield, G. & Kay, R. R. Uses and abuses of macropinocytosis. J. Cell Sci. 129, 2697\u20132705 (2016).","journal-title":"J. Cell Sci."},{"key":"1916_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/BJ20101864","volume":"435","author":"X Wang","year":"2011","unstructured":"Wang, X. et al. ER stress modulates cellular metabolism. Biochem. J. 435, 285\u2013296 (2011).","journal-title":"Biochem. J."},{"key":"1916_CR22","doi-asserted-by":"crossref","first-page":"36461","DOI":"10.18632\/oncotarget.9263","volume":"7","author":"H Liu","year":"2016","unstructured":"Liu, H. et al. Combining 2-deoxy-d-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress. Oncotarget 7, 36461\u201336473 (2016).","journal-title":"Oncotarget"},{"key":"1916_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ijc.2910510220","volume":"51","author":"D Schmitter","year":"1992","unstructured":"Schmitter, D., Lauber, B., Fagg, B. & Stahel, R. A. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int. J. Cancer 51, 296\u2013301 (1992).","journal-title":"Int. J. Cancer"},{"key":"1916_CR24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3389\/fphar.2017.00970","volume":"8","author":"DB Oien","year":"2017","unstructured":"Oien, D. B., Garay, T., Eckstein, S. & Chien, J. Cisplatin and pemetrexed activate AXL and AXL inhibitor BGB324 enhances mesothelioma cell death from chemotherapy. Front. Pharmacol. 8, 970 (2017).","journal-title":"Front. Pharmacol."},{"key":"1916_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22143-w","volume":"8","author":"S Sarkar Bhattacharya","year":"2018","unstructured":"Sarkar Bhattacharya, S., Mandal, C., Albiez, R. S., Samanta, S. K. & Mandal, C. Mahanine drives pancreatic adenocarcinoma cells into endoplasmic reticular stress-mediated apoptosis through modulating sialylation process and Ca(2+)-signaling. Sci. Rep. 8, 3911 (2018).","journal-title":"Sci. Rep."},{"key":"1916_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10495-013-0907-6","volume":"19","author":"R Das","year":"2014","unstructured":"Das, R. et al. Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53\/p73 in colon carcinoma. Apoptosis 19, 149\u2013164 (2014).","journal-title":"Apoptosis"},{"key":"1916_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/ERC-13-0315","volume":"21","author":"S Sarkar","year":"2014","unstructured":"Sarkar, S., Mandal, C., Sangwan, R. & Mandal, C. Coupling G2\/M arrest to the Wnt\/beta-catenin pathway restrains pancreatic adenocarcinoma. Endocr. Relat. Cancer 21, 113\u2013125 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"1916_CR28","doi-asserted-by":"publisher","first-page":"33705","DOI":"10.18632\/oncotarget.5605","volume":"6","author":"S Mondal","year":"2015","unstructured":"Mondal, S. et al. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget 6, 33705\u201333719 (2015).","journal-title":"Oncotarget"},{"key":"1916_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ijc.27687","volume":"132","author":"S Sarkar","year":"2013","unstructured":"Sarkar, S. et al. Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. Int. J. Cancer 132, 695\u2013706 (2013).","journal-title":"Int. J. Cancer"},{"key":"1916_CR30","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1172\/JCI115361","volume":"88","author":"MC Corretti","year":"1991","unstructured":"Corretti, M. C. et al. Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J. Clin. Invest. 88, 1014\u20131025 (1991).","journal-title":"J. Clin. Invest."},{"key":"1916_CR31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1042\/bj1010480","volume":"101","author":"FL Bygrave","year":"1966","unstructured":"Bygrave, F. L. The effect of calcium ions on the glycolytic activity of Ehrlich ascites-tumour cells. Biochem. J. 101, 480\u2013487 (1966).","journal-title":"Biochem. J."},{"key":"1916_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891\u2013899 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"1916_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.20120162","volume":"209","author":"RB Hamanaka","year":"2012","unstructured":"Hamanaka, R. B. & Chandel, N. S. Targeting glucose metabolism for cancer therapy. J. Exp. Med. 209, 211\u2013215 (2012).","journal-title":"J. Exp. Med"},{"key":"1916_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/bjc.2016.256","volume":"115","author":"E Michalopoulou","year":"2016","unstructured":"Michalopoulou, E., Bulusu, V. & Kamphorst, J. J. Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating. Br. J. Cancer 115, 635\u2013640 (2016).","journal-title":"Br. J. Cancer"},{"key":"1916_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/jmcb\/mjx011","volume":"9","author":"Y Cui","year":"2017","unstructured":"Cui, Y. et al. Determination of glucose deficiency-induced cell death by mitochondrial ATP generation-driven proton homeostasis. J. Mol. Cell Biol. 9, 395\u2013408 (2017).","journal-title":"J. Mol. Cell Biol."},{"key":"1916_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5288-y","volume":"19","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. BMC Cancer 19, 77 (2019).","journal-title":"BMC Cancer"},{"key":"1916_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.bbamcr.2017.01.009","volume":"1864","author":"JM van der Harg","year":"2017","unstructured":"van der Harg, J. M. et al. The UPR reduces glucose metabolism via IRE1 signaling. Biochim. Biophys. Acta Mol. Cell Res. 1864, 655\u2013665 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1916_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519\u2013529 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1916_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-018-4874-z","volume":"171","author":"A Berthe","year":"2018","unstructured":"Berthe, A. et al. Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells. Breast Cancer Res. Treat. 171, 581\u2013591 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"1916_CR40","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1128\/AAC.01126-12","volume":"56","author":"HJ Leung","year":"2012","unstructured":"Leung, H. J. et al. Activation of the unfolded protein response by 2-deoxy-d-glucose inhibits Kaposi\u2019s Sarcoma-associated herpesvirus replication and gene expression. Antimicrob. Agents Chemother. 56, 5794\u20135803 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1916_CR41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/1440-1681.12537","volume":"43","author":"J Qu","year":"2016","unstructured":"Qu, J. et al. PFKFB3 modulates glycolytic metabolism and alleviates endoplasmic reticulum stress in human osteoarthritis cartilage. Clin. Exp. Pharmacol. Physiol. 43, 312\u2013318 (2016).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1916_CR42","doi-asserted-by":"crossref","first-page":"62793","DOI":"10.18632\/oncotarget.19513","volume":"8","author":"L Lu","year":"2017","unstructured":"Lu, L., Chen, Y. & Zhu, Y. The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer. Oncotarget 8, 62793\u201362802 (2017).","journal-title":"Oncotarget"},{"key":"1916_CR43","first-page":"359","volume":"42","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells. Int. J. Mol. Med. 42, 359\u2013367 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"1916_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/leu.2011.225","volume":"26","author":"MM Reddy","year":"2012","unstructured":"Reddy, M. M. et al. The JAK2V617F oncogene requires expression of inducible phosphofructokinase\/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. Leukemia 26, 481\u2013489 (2012).","journal-title":"Leukemia"},{"key":"1916_CR45","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1084\/jem.20130252","volume":"210","author":"Z Yang","year":"2013","unstructured":"Yang, Z., Fujii, H., Mohan, S. V., Goronzy, J. J. & Weyand, C. M. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J. Exp. Med. 210, 2119\u20132134 (2013).","journal-title":"J. Exp. Med."},{"key":"1916_CR46","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1021\/jm501997q","volume":"58","author":"CJ Trabbic","year":"2015","unstructured":"Trabbic, C. J. et al. Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity. J. Med. Chem. 58, 2489\u20132512 (2015).","journal-title":"J. Med. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1916-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1916-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1916-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T12:38:12Z","timestamp":1671194292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1916-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1916-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"assertion":[{"value":"12 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"725"}}